16/09 2022 Non-regulatory Redsense presents at Aktiedagen Lund Monday, September 26, 2022, Redsense participates in Aktiespararna’s event Aktiedagen Lund. Pontus Nobréus, CEO, will present the company and answer your questions. The presentation will… [read more]
15/09 2022 Non-regulatory New article brings forward support for home dialysis in connection with comorbidities Redsense Medical notes that a new scientific article is presenting emerging evidence that strengthens the case for home hemodialysis over in-center treatment. Home hemodialysis is… [read more]
29/08 2022 Regulatory Interim Report Q2 – April – June, 2022 Redsense Medical AB (publ) April – June 2022 · Net sales amounted to kSEK 1,927 (1,479), an increase by 30.3 percent. · Operating loss, EBIT amounted to kSEK 2,428… [read more]
